Legal & General Group PLC Gossamer Bio, Inc. Transaction History

Legal & General Group PLC

$431 Billion
Q3 2025

A detailed history of Legal & General Group PLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 20,891 shares of GOSS stock, worth $56,614. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,891

Previous 21,159 1.27%

Holding current value

$56,614

Previous $26,000 107.69%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$1.21 - $3.46 $324 - $927	-268 Reduced 1.27%	20,891 $54,000
Q2 2025 Aug 12, 2025	BUY	$0.78 - $1.44 $16,504 - $30,468	21,159 New	21,159 $26,000
Q1 2023 May 15, 2023	SELL	$0.96 - $2.92 $12,590 - $38,295	-13,115 Reduced 63.77%	7,451 $9,000
Q4 2022 Feb 14, 2023	SELL	$1.74 - $12.87 $713 - $5,276	-410 Reduced 1.95%	20,566 $44,000
Q3 2022 Nov 14, 2022	BUY	$7.21 - $14.88 $22,170 - $45,756	3,075 Added 17.18%	20,976 $251,000

Q2 2022 Aug 22, 2022	SELL	$5.97 - $9.97 $752 - $1,256	-126 Reduced 0.7%	17,901 $150,000
Q1 2022 May 16, 2022	BUY	$8.44 - $12.49 $4,000 - $5,920	474 Added 2.7%	18,027 $156,000
Q4 2021 Feb 14, 2022	SELL	$10.12 - $14.07 $2,884 - $4,009	-285 Reduced 1.6%	17,553 $199,000
Q3 2021 Nov 15, 2021	BUY	$7.25 - $13.23 $72,478 - $132,260	9,997 Added 127.5%	17,838 $225,000
Q2 2021 Aug 12, 2021	SELL	$8.0 - $9.75 $4,992 - $6,084	-624 Reduced 7.37%	7,841 $63,000
Q1 2021 May 17, 2021	SELL	$8.63 - $10.94 $1,829 - $2,319	-212 Reduced 2.44%	8,465 $79,000
Q3 2020 Nov 13, 2020	SELL	$11.3 - $14.75 $16,317 - $21,299	-1,444 Reduced 14.27%	8,677 $107,000
Q2 2020 Aug 14, 2020	BUY	$9.52 - $15.98 $28,502 - $47,844	2,994 Added 42.01%	10,121 $132,000
Q1 2020 May 14, 2020	SELL	$8.0 - $15.48 $15,616 - $30,216	-1,952 Reduced 21.5%	7,127 $72,000
Q4 2019 Feb 13, 2020	BUY	$14.82 - $26.79 $14,167 - $25,611	956 Added 11.77%	9,079 $141,000
Q3 2019 Nov 13, 2019	BUY	$16.02 - $22.47 $60,859 - $85,363	3,799 Added 87.86%	8,123 $137,000
Q2 2019 Aug 14, 2019	BUY	$16.12 - $22.89 $41,541 - $58,987	2,577 Added 147.51%	4,324 $96,000
Q1 2019 May 15, 2019	BUY	$17.58 - $23.97 $30,712 - $41,875	1,747 New	1,747 $38,000

Others Institutions Holding GOSS

# of Institutions

182

Shares Held

163M

Call Options Held

8.11M

Put Options Held

211K

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $255M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Gossamer Bio, Inc. Transaction History